Collaborative Medicinal Development
Ken Goldman is the Intellectual Property Counsel for Cthulhu Ventures LLC and for a number of companies in which Cthulhu Ventures, CMD’s founding investor, has invested including CMD and, inter alia, Warner Babcock Institute for Green Chemistry. Over 20 years of experience managing IP issues for biotechnology and diagnostics companies. He was a former IP Director at Novartis, Dynavax, Cell Genesys, and Chiron Corporation.
This person is not in the org chart
This person is not in any offices
Collaborative Medicinal Development
Collaborative Medicinal Development is a clinical stage company developing novel disease modifying drugs for the treatment of both neurodegenerative diseases and cancer. They are building a portfolio by both inventing new chemical entities in house and licensing promising leads from third parties.